New regulations that require pharmaceutical companies to report expected shortages for certain kinds of drugs six months before the shortages occur will not help solve the problem, according to a Mackinac Center expert. John Graham, director of health studies at the Pacific Research Institute and an adjunct scholar with the Center, explains the problem in a Detroit Free Press commentary today. He takes a closer look and offers solutions in this recent study.
Permission to reprint this blog post in whole or in part is hereby granted, provided that the author (or authors) and the Mackinac Center for Public Policy are properly cited. Permission to reprint any comments below is granted only for those comments written by Mackinac Center policy staff.
Get insightful commentary and the most reliable research on Michigan issues sent straight to your inbox.
The Mackinac Center for Public Policy is a nonprofit research and educational institute that advances the principles of free markets and limited government. Through our research and education programs, we challenge government overreach and advocate for a free-market approach to public policy that frees people to realize their potential and dreams.
Please consider contributing to our work to advance a freer and more prosperous state.